Stay updated on Setmelanotide in BBS and AS for Obesity Clinical Trial

Sign up to get notified when there's something new on the Setmelanotide in BBS and AS for Obesity Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Setmelanotide in BBS and AS for Obesity Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    Change Detected
    Summary
    The study has expanded to include 12 locations, and the revision has been updated from v2.9.7 to v2.10.0.
    Difference
    0.3%
    Check dated 2024-07-23T15:00:44.000Z thumbnail image
  5. Check
    5 days ago
    No Change Detected
  6. Check
    11 days ago
    Change Detected
    Summary
    The website has been updated to Revision v2.9.7 from v2.9.6.
    Difference
    0.1%
    Check dated 2024-07-16T08:23:00.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-07-02T14:39:46.000Z thumbnail image
  8. Check
    30 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.3 to v2.9.5, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-27T10:30:52.000Z thumbnail image
  9. Check
    31 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.1 to v2.9.3, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-26T09:26:38.000Z thumbnail image
  10. Check
    32 days ago
    Change Detected
    Summary
    The value on the web page has changed from 'Show more Revision: v2.9.0' to 'MedlinePlus Genetics related topics: Bardet-Biedl syndrome, Alström syndrome, and more. Design details, primary and secondary outcome measures, and study plan for a Phase 3 trial of Setmelanotide in Bardet-Biedl Syndrome and Alström Syndrome participants with moderate to severe obesity.'
    Difference
    45%
    Check dated 2024-06-25T08:37:19.000Z thumbnail image

Stay in the know with updates to Setmelanotide in BBS and AS for Obesity Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Setmelanotide in BBS and AS for Obesity Clinical Trial page.